Your browser doesn't support javascript.
loading
Author Correction: Selective optogenetic control of Gq signaling using human Neuropsin.
Wagdi, Ahmed; Malan, Daniela; Sathyanarayanan, Udhayabhaskar; Beauchamp, Janosch S; Vogt, Markus; Zipf, David; Beiert, Thomas; Mansuroglu, Berivan; Dusend, Vanessa; Meininghaus, Mark; Schneider, Linn; Kalthof, Bernd; Wiegert, J Simon; König, Gabriele M; Kostenis, Evi; Patejdl, Robert; Sasse, Philipp; Bruegmann, Tobias.
Afiliación
  • Wagdi A; Institute for Cardiovascular Physiology, University Medical Center Göttingen, Göttingen, Germany.
  • Malan D; German Center for Cardiovascular Research (DZHK), Partner site Göttingen, Göttingen, Germany.
  • Sathyanarayanan U; Department of Cardiology and Pulmonology, University Medical Center Göttingen, Georg August University of Göttingen, Göttingen, Germany.
  • Beauchamp JS; Institute of Physiology I, Medical Faculty, University of Bonn, Bonn, Germany.
  • Vogt M; Institute for Cardiovascular Physiology, University Medical Center Göttingen, Göttingen, Germany.
  • Zipf D; Institute for Cardiovascular Physiology, University Medical Center Göttingen, Göttingen, Germany.
  • Beiert T; Institute for Cardiovascular Physiology, University Medical Center Göttingen, Göttingen, Germany.
  • Mansuroglu B; Institute for Cardiovascular Physiology, University Medical Center Göttingen, Göttingen, Germany.
  • Dusend V; Department of Internal Medicine II, University Hospital Bonn, University of Bonn, Bonn, Germany.
  • Meininghaus M; Institute of Physiology I, Medical Faculty, University of Bonn, Bonn, Germany.
  • Schneider L; Research Training Group 1873, University of Bonn, Bonn, Germany.
  • Kalthof B; Institute of Physiology I, Medical Faculty, University of Bonn, Bonn, Germany.
  • Wiegert JS; Research Training Group 1873, University of Bonn, Bonn, Germany.
  • König GM; Bayer AG, Research & Development, Pharmaceuticals, 42096, Wuppertal, Germany.
  • Kostenis E; Bayer AG, Research & Development, Pharmaceuticals, 42096, Wuppertal, Germany.
  • Patejdl R; Bayer AG, Research & Development, Pharmaceuticals, 42096, Wuppertal, Germany.
  • Sasse P; Center for Molecular Neurobiology Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Bruegmann T; Molecular, Cellular and Pharmacobiology Section, Institute of Pharmaceutical Biology, University of Bonn, Bonn, Germany.
Nat Commun ; 14(1): 58, 2023 Jan 04.
Article en En | MEDLINE | ID: mdl-36599836
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2023 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2023 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido